The possibility of a posttransfusion chronic
hepatitis is not excluded, although histologically
liver morphology is not believed to be typical of a
viral hepatitis. HCV RNA by PCR and hepatitis C
antibody remain negative; the patient has been
vaccinated against hepatitis B. The etiopathogenesis
of NASH, and the reason for its ‘‘recurrence’’ in
a transplanted liver, remain unknown